Skip to main content
Top
Published in: Journal of Gastroenterology 4/2020

01-04-2020 | Chronic Pancreatitis | Letter to the Editor

Statins and pancreatic cancer risk

Authors: Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

Published in: Journal of Gastroenterology | Issue 4/2020

Login to get access

Excerpt

Statins are used to treat hypercholesterolemia, but they have a potential effect on cancer risk. The correlation between statins use and pancreatic cancer risk has been examined in different study populations. A cohort study in Taiwan reported that statins users among patients with type 2 diabetes had a lower incidence rate of pancreatic cancer comparing with non-users (incidence rate ratio 0.46) [1]. Two prospective cohort studies in USA conducted by Hamada et al. published in Journal of Gastroenterology reported that statins use was not statistically associated with the risk of pancreatic cancer in the general population (adjusted odds ratio 0.98 and 95% confidence interval 0.82–1.16) [2]. Their findings were compatible with a case–control study in Taiwan showing that statins use was not statistically associated with the risk of pancreatic cancer in the general population (adjusted odds ratio 0.87 and 95% confidence interval 0.56–1.36) [3]. …
Literature
1.
go back to reference Chen MJ, Tsan YT, Liou JM, et al. Statins and the risk of pancreatic cancer in type 2 diabetic patients—a population-based cohort study. Int J Cancer. 2016;138:594–603.CrossRef Chen MJ, Tsan YT, Liou JM, et al. Statins and the risk of pancreatic cancer in type 2 diabetic patients—a population-based cohort study. Int J Cancer. 2016;138:594–603.CrossRef
2.
go back to reference Hamada T, Khalaf N, Yuan C, et al. Statin use and pancreatic cancer risk in two prospective cohort studies. J Gastroenterol. 2018;53:959–66.CrossRef Hamada T, Khalaf N, Yuan C, et al. Statin use and pancreatic cancer risk in two prospective cohort studies. J Gastroenterol. 2018;53:959–66.CrossRef
3.
go back to reference Chiu HF, Chang CC, Ho SC, et al. Statin use and the risk of pancreatic cancer: a population-based case–control study. Pancreas. 2011;40:669–72.CrossRef Chiu HF, Chang CC, Ho SC, et al. Statin use and the risk of pancreatic cancer: a population-based case–control study. Pancreas. 2011;40:669–72.CrossRef
5.
go back to reference Lai SW, Lin CL, Chang Ou KC, et al. Association between acute pancreatitis and pancreatic cancer. Eur J Gastroenterol Hepatol. 2019;31:896–7.CrossRef Lai SW, Lin CL, Chang Ou KC, et al. Association between acute pancreatitis and pancreatic cancer. Eur J Gastroenterol Hepatol. 2019;31:896–7.CrossRef
6.
go back to reference Kirkegard J, Lund JL, Mortensen FV, et al. Statins and pancreatic cancer risk in patients with chronic pancreatitis: a Danish nationwide population-based cohort study. Int J Cancer. 2020;146:610–6.CrossRef Kirkegard J, Lund JL, Mortensen FV, et al. Statins and pancreatic cancer risk in patients with chronic pancreatitis: a Danish nationwide population-based cohort study. Int J Cancer. 2020;146:610–6.CrossRef
7.
go back to reference Bang UC, Watanabe T, Bendtsen F. The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis. Eur J Gastroenterol Hepatol. 2018;30:346–51.CrossRef Bang UC, Watanabe T, Bendtsen F. The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis. Eur J Gastroenterol Hepatol. 2018;30:346–51.CrossRef
Metadata
Title
Statins and pancreatic cancer risk
Authors
Shih-Wei Lai
Yu-Hung Kuo
Kuan-Fu Liao
Publication date
01-04-2020
Publisher
Springer Singapore
Published in
Journal of Gastroenterology / Issue 4/2020
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-020-01675-x

Other articles of this Issue 4/2020

Journal of Gastroenterology 4/2020 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016